Literature DB >> 19683146

Using Rasch analysis to revisit the validity of the Cataract TyPE Spec instrument for measuring cataract surgery outcomes.

Vijaya K Gothwal1, Thomas A Wright, Ecosse L Lamoureux, Konrad Pesudovs.   

Abstract

PURPOSE: To assess the psychometric properties of the Cataract TyPE Specification (Spec) questionnaire using the Rasch model.
SETTING: Flinders Medical Centre, Adelaide, Australia.
METHODS: The 12-item Cataract TyPE Spec questionnaire was self-administered to patients drawn from the cataract surgery waiting list. The questionnaire and its 5 subscales were assessed for fit to the Rasch model. Response category performance, item-fit targeting, unidimensionality (using principal components analysis), and differential item functioning were assessed. A shortened version (11 items) was tested for criterion validity by determining correlation with a global rating of vision question.
RESULTS: Two hundred ninety-four patients responded to the questionnaire. The response categories for each question functioned as intended. Person-separation reliability was high (0.90). Deletion of 1 misfitting item (nighttime driving) improved overall model fit. The principal components analysis of the residuals demonstrated unidimensionality for the 11-item Cataract TyPE Spec and 2 subscales. However, items were targeted to a less able population. Only 2 subscales (near vision and glare) were valid. There was a good statistically significant correlation between the Likert-scored global rating of vision and the Rasch-scaled Cataract TyPE Spec score (r = -0.66, P<.0001), suggesting good criterion validity.
CONCLUSIONS: With minor modifications, the Cataract TyPE Spec questionnaire and its glare and near-vision subscales were good measures of visual functioning in the cataract patient. Additional items to suit the more able, including patients having second-eye surgery, could improve the measurement properties.

Entities:  

Mesh:

Year:  2009        PMID: 19683146     DOI: 10.1016/j.jcrs.2009.03.056

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Measuring Health-Related Quality of Life in Strabismus: A Modification of the Adult Strabismus-20 (AS-20) Questionnaire Using Rasch Analysis.

Authors:  Vijaya K Gothwal; Seelam Bharani; Ramesh Kekunnaya; PreetiPatil Chhablani; Virender Sachdeva; Niranjan K Pehere; Asa Narasaiah; Rekha Gunturu
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

2.  Measuring coping in parents of children with disabilities: a rasch model approach.

Authors:  Vijaya K Gothwal; Seelam Bharani; Shailaja P Reddy
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

3.  Catquest-9SF questionnaire: validation of Malay and Chinese-language versions using Rasch analysis.

Authors:  Tassha Hilda Adnan; Mokhlisoh Mohamed Apandi; Haireen Kamaruddin; Mohamad Aziz Salowi; Kian Boon Law; Jamaiyah Haniff; Pik Pin Goh
Journal:  Health Qual Life Outcomes       Date:  2018-01-05       Impact factor: 3.186

4.  An alternative application of Rasch analysis to assess data from ophthalmic patient-reported outcome instruments.

Authors:  Richard N McNeely; Salissou Moutari; Samuel Arba-Mosquera; Shwetabh Verma; Jonathan E Moore
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

5.  Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients.

Authors:  Yu-Jun Chang; Wen-Miin Liang; Hsi-Chin Wu; Hsueh-Chun Lin; Jong-Yi Wang; Tsai-Chung Li; Yi-Chun Yeh; Chih-Hung Chang
Journal:  Health Qual Life Outcomes       Date:  2012-08-20       Impact factor: 3.186

6.  Focussing both eyes on health outcomes: revisiting cataract surgery.

Authors:  Jennifer C Davis; Heather McNeill; Michael Wasdell; Susan Chunick; Stirling Bryan
Journal:  BMC Geriatr       Date:  2012-09-03       Impact factor: 3.921

7.  The importance of rating scales in measuring patient-reported outcomes.

Authors:  Jyoti Khadka; Vijaya K Gothwal; Colm McAlinden; Ecosse L Lamoureux; Konrad Pesudovs
Journal:  Health Qual Life Outcomes       Date:  2012-07-13       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.